Clinical Trials

Sex disparities continue in CV scientific leadership, as women are not often present in leadership roles of CV clinical trials published in major journals, researchers found.

Four institutions have become members of the Pediatric Brain Tumor Consortium.

Every detail counts when participating in clinical trials, according to one panelist at the virtual Women in Ophthalmology Summer Symposium.

Through its clinical research subsidiary, DaVita Inc. has begun enrolling participants for two trials designed to investigate the ways in which COVID-19 impacts patients with end-stage kidney disease who are currently receiving dialysis.

A collaborative global master clinical trial by The Leukemia & Lymphoma Society, Children’s Oncology Group and NCI aims to meaningfully advance the development of targeted treatments for children with acute leukemia.

Edward Chu, MD, MMS, has been named director of Albert Einstein Cancer Center.

Two prominent oncology organizations have launched a collaboration designed to increase racial and ethnic diversity in cancer clinical trials.

The COVID-19 outbreak and subsequent disruptions to daily life, working conditions and the economy have had a profound impact on how clinical trials for cancer are conducted, with potentially lasting implications.

As an oncologist who treats melanoma, Antoni Ribas, MD, PhD, typically views skin color from a strictly scientific perspective.

Increased attention should be paid to the conclusions of formally negative trials discussed during oral presentations at oncology meetings, as many convey a not-negative message, according to a research letter published in JAMA Oncology.